应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
MNKD 曼恩凯德生物医疗
盘前交易 12-24 08:12:33 EST
7.02
+0.17
+2.48%
盘前
6.84
-0.18
-2.56%
05:23 EST
最高
7.04
最低
6.73
成交量
323.80万
今开
6.73
昨收
6.85
日振幅
4.53%
总市值
19.36亿
流通市值
18.93亿
总股本
2.76亿
成交额
2,256万
换手率
1.20%
流通股本
2.70亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
曼恩凯德生物医疗盘中异动 早盘股价大涨5.16%报6.63美元
市场透视 · 12-20
曼恩凯德生物医疗盘中异动 早盘股价大涨5.16%报6.63美元
美国研究综述-亚马逊、万事达卡、特斯拉
路透中文 · 12-19
美国研究综述-亚马逊、万事达卡、特斯拉
曼恩凯德生物医疗盘中异动 股价大涨5.06%报6.23美元
市场透视 · 12-18
曼恩凯德生物医疗盘中异动 股价大涨5.06%报6.23美元
曼恩凯德生物医疗盘中异动 股价大跌5.10%报5.95美元
市场透视 · 12-17
曼恩凯德生物医疗盘中异动 股价大跌5.10%报5.95美元
BUZZ--美国股票走势-Candel Therapeutics、Broadcom、Reddit
Reuters · 12-12
BUZZ--美国股票走势-Candel Therapeutics、Broadcom、Reddit
BUZZ--美国股票走势-埃克森美孚、Mondelez International、梅西百货
路透中文 · 12-11
BUZZ--美国股票走势-埃克森美孚、Mondelez International、梅西百货
BUZZ-印度批准胰岛素吸入粉后,MannKind 公司业绩上升
Reuters · 12-11
BUZZ-印度批准胰岛素吸入粉后,MannKind 公司业绩上升
曼恩凯德生物医疗盘中异动 快速下跌5.01%报6.38美元
市场透视 · 11-26
曼恩凯德生物医疗盘中异动 快速下跌5.01%报6.38美元
曼恩凯德生物医疗2024财年第三财季实现净利润11.55百万美元,同比增加571.51%
市场透视 · 11-17
曼恩凯德生物医疗2024财年第三财季实现净利润11.55百万美元,同比增加571.51%
曼恩凯德生物医疗盘中异动 临近午盘快速上涨5.32%报7.33美元
市场透视 · 11-15
曼恩凯德生物医疗盘中异动 临近午盘快速上涨5.32%报7.33美元
曼恩凯德生物医疗盘中异动 早盘股价大跌9.42%
市场透视 · 11-08
曼恩凯德生物医疗盘中异动 早盘股价大跌9.42%
MannKind Corp 预计每股收益3美分 - 财报前瞻
Reuters · 11-06
MannKind Corp 预计每股收益3美分 - 财报前瞻
曼恩凯德生物医疗盘中异动 快速拉升5.20%报6.88美元
市场透视 · 10-28
曼恩凯德生物医疗盘中异动 快速拉升5.20%报6.88美元
曼恩凯德生物医疗盘中异动 快速拉升5.17%报6.62美元
市场透视 · 10-03
曼恩凯德生物医疗盘中异动 快速拉升5.17%报6.62美元
曼恩凯德生物医疗盘中异动 早盘急速拉升5.06%
自选股智能写手 · 08-19
曼恩凯德生物医疗盘中异动 早盘急速拉升5.06%
曼恩凯德生物医疗2024财年第二财季实现净利润-2.01百万美元,同比增加61.86%
自选股智能写手 · 08-17
曼恩凯德生物医疗2024财年第二财季实现净利润-2.01百万美元,同比增加61.86%
MannKind Corp 预计每股收益1美分 - 财报前瞻
Reuters · 08-05
MannKind Corp 预计每股收益1美分 - 财报前瞻
曼恩凯德生物医疗盘中异动 股价大跌6.37%报5.00美元
自选股智能写手 · 08-05
曼恩凯德生物医疗盘中异动 股价大跌6.37%报5.00美元
曼恩凯德生物医疗盘中异动 急速上涨5.07%
自选股智能写手 · 07-09
曼恩凯德生物医疗盘中异动 急速上涨5.07%
曼恩凯德生物医疗盘中异动 快速拉升5.19%报5.38美元
自选股智能写手 · 06-25
曼恩凯德生物医疗盘中异动 快速拉升5.19%报5.38美元
暂无数据
公司概况
公司名称:
曼恩凯德生物医疗
所属市场:
NASDAQ
上市日期:
--
主营业务:
Mannkind Corporation于1991年2月14日在美国特拉华州注册成立。Mannkind Corporation是一家生物制药公司,侧重于诸如糖尿病和癌症之类疗法和药品的开发、研制和推广。该公司的主导候选产品——AFREZZA吸入粉末,是一种超速效胰岛素,处于后期临床研究阶段,用于成人1型或2型糖尿病高血糖的控制治疗。AFREZZA是由该公司的专有技术圈颗粒加载到胰岛素分子里。这些加载的粒子雾化吸入后,会深入到使用AFREZZA吸入器的肺部。糖尿病是一个重大的健康问题。
发行价格:
--
{"stockData":{"symbol":"MNKD","market":"US","secType":"STK","nameCN":"曼恩凯德生物医疗","latestPrice":7.02,"timestamp":1734987600000,"preClose":6.85,"halted":0,"volume":3237992,"hourTrading":{"tag":"盘前","latestPrice":6.84,"preClose":7.02,"latestTime":"05:23 EST","volume":15,"amount":102.36,"timestamp":1735035817206},"delay":0,"floatShares":269679972,"shares":275777693,"eps":0.079282,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.17,"latestTime":"12-24 08:12:33 EST","open":6.73,"high":7.04,"low":6.73,"amount":22560502.99991,"amplitude":0.045255,"askPrice":7.13,"askSize":200,"bidPrice":6.3,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.079282,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1735050600000},"adr":0,"listingDate":1090987200000,"adjPreClose":7.02,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":6.84,"preClose":7.02,"latestTime":"05:23 EST","volume":15,"amount":102.36,"timestamp":1735035817206},"postHourTrading":{"tag":"盘后","latestPrice":7.0993,"preClose":7.02,"latestTime":"19:39 EST","volume":168109,"amount":1180197.8435,"timestamp":1735000743224},"volumeRatio":0.6250271447143796,"optionData":{"bulkOrders":[{"symbol":"MNKD","call":true,"expireDate":1740114000000,"strike":"7.0","timestamp":1734986602060,"price":0.6800000071525574,"volume":3126,"amount":212568,"type":"-"}]},"impliedVol":0.4106,"impliedVolPercentile":0.4622},"requestUrl":"/m/hq/s/MNKD/tweets","defaultTab":"tweets","newsList":[{"id":"2492444009","title":"曼恩凯德生物医疗盘中异动 早盘股价大涨5.16%报6.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492444009","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492444009?lang=zh_cn&edition=full","pubTime":"2024-12-20 22:37","pubTimestamp":1734705463,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日22时37分,曼恩凯德生物医疗股票出现波动,股价快速上涨5.16%。截至发稿,该股报6.63美元/股,成交量51.8372万股,换手率0.19%,振幅4.60%。机构评级方面,在所有6家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。曼恩凯德生物医疗股票所在的生物技术行业中,整体跌幅为0.25%。曼恩凯德生物医疗公司简介:MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223743ab8767a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223743ab8767a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4584","MNKD"],"gpt_icon":0},{"id":"2492468114","title":"美国研究综述-亚马逊、万事达卡、特斯拉","url":"https://stock-news.laohu8.com/highlight/detail?id=2492468114","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492468114?lang=zh_cn&edition=full","pubTime":"2024-12-19 14:58","pubTimestamp":1734591497,"startTime":"0","endTime":"0","summary":"美国研究综述-亚马逊、万事达卡、特斯拉路透12月19日 - 华尔街证券分析师周四调整了对亚马逊、万事达卡和特斯拉等多家美国上市公司的评级和目标价。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nL4T3NK0JV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DSP","TSYW.SI","MNKD","LU0672654240.SGD","WOR","LU2456880835.USD","S","LU1989772923.USD","NET","AIN","TGI","GIS","ASLE","TENB","META","V","MNRO","BROS","WM","LU0096362180.USD","OKTA","USAW.SI","LU0444971666.USD","FTNT","LU1674673691.USD","CRMD","UPWK","TKO","EAT","HXL","TPR","FI","LU0820561909.HKD","ANAB","VRNS","IE00BJJMRY28.SGD","PANW","LU1121112475.USD","TSLA","FHN","MA","ZG","ACHC","LU0708994859.HKD","AMZN"],"gpt_icon":1},{"id":"2492184919","title":"曼恩凯德生物医疗盘中异动 股价大涨5.06%报6.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492184919","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492184919?lang=zh_cn&edition=full","pubTime":"2024-12-18 22:53","pubTimestamp":1734533614,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日22时53分,曼恩凯德生物医疗股票出现异动,股价快速上涨5.06%。截至发稿,该股报6.23美元/股,成交量52.322万股,换手率0.19%,振幅2.85%。机构评级方面,在所有5家参与评级的机构中,80%的券商给予买入建议,20%的券商给予持有建议,无券商给予卖出建议。曼恩凯德生物医疗股票所在的生物技术行业中,整体跌幅为0.48%。曼恩凯德生物医疗公司简介:MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121822533595ea554e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121822533595ea554e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNKD","BK4584","BK4139"],"gpt_icon":0},{"id":"2492965437","title":"曼恩凯德生物医疗盘中异动 股价大跌5.10%报5.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492965437","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492965437?lang=zh_cn&edition=full","pubTime":"2024-12-17 22:43","pubTimestamp":1734446618,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日22时43分,曼恩凯德生物医疗股票出现异动,股价急速下跌5.10%。截至发稿,该股报5.95美元/股,成交量40.2456万股,换手率0.15%,振幅3.67%。最近的财报数据显示,该股实现营业收入70.08百万美元,净利润11.55百万美元,每股收益0.04美元,毛利52.06百万美元,市盈率74.88倍。曼恩凯德生物医疗股票所在的生物技术行业中,整体涨幅为0.56%。曼恩凯德生物医疗公司简介:MannKind Corp是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217224338984c908b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217224338984c908b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNKD","BK4139","BK4584"],"gpt_icon":0},{"id":"2490374862","title":"BUZZ--美国股票走势-Candel Therapeutics、Broadcom、Reddit","url":"https://stock-news.laohu8.com/highlight/detail?id=2490374862","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490374862?lang=zh_cn&edition=full","pubTime":"2024-12-12 00:18","pubTimestamp":1733933898,"startTime":"0","endTime":"0","summary":" * 个股走势的 Eikon 搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 12月11日 - 华尔街主要股指周三上涨,此前的通胀数据维持了对美联储本月晚些时候降息的押注不变。美东时间10:30,道琼斯工业平均指数 上涨0.03%,报44,259.91点。标普500指数 上涨0.66%,报6,074.64点;纳斯达克综合指数 上涨1.26%,报19,935.91点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDLZ","AMZN","FLNC","CLRB","GM","PLD","CGON","ALK","PDCO","MNKD","SIRI",".SPX","AZO","MNQmain","LENZ","QID",".DJI","XOM","UDOW","SFIX","AVGO",".IXIC","FIGS","LOAR","ACI","GEV","PLAY","NQmain","EGP","CCB","ANVS","M","PSQ","RCKT","SDOW","TQQQ","QTTB","GTLS","LUV","RDDT","DNUT","IBRX","AVGOP","RLAY","OMC","DOG","CADL","QLD","DJX"],"gpt_icon":1},{"id":"2490850527","title":"BUZZ--美国股票走势-埃克森美孚、Mondelez International、梅西百货","url":"https://stock-news.laohu8.com/highlight/detail?id=2490850527","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490850527?lang=zh_cn&edition=full","pubTime":"2024-12-11 22:11","pubTimestamp":1733926289,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nL4T3NC12G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0795875086.SGD","LU1150488218.USD","FIGS","LU1732799900.SGD","RCKT","LUV","RJF","LU0345770308.USD","LU2602419157.SGD","DNUT","LU2249611893.SGD","BK4559","SFIX","SG9999014567.USD","ANVS","EGP","GM","ALK","QTTB","LU0738911758.USD","RLAY","PLD","XOM","CLRB","LU0130103400.USD","LU1481011911.USD","LU0170899867.USD","LU0011850046.USD","CADL","GEV","M","LU0612318385.USD","MNKD","BK4077","CGON","LU2505996509.AUD","LU1066053197.SGD","LU0070302665.USD","SG9999015341.SGD","OMC","LU1929549753.HKD","FLNC","LU0320765489.SGD","SIRI","PLAY","LU1430597077.USD","MDLZ","PDCO","IBRX"],"gpt_icon":1},{"id":"2490985936","title":"BUZZ-印度批准胰岛素吸入粉后,MannKind 公司业绩上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2490985936","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490985936?lang=zh_cn&edition=full","pubTime":"2024-12-11 20:43","pubTimestamp":1733921027,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 12月11日 - ** 制药商MannKind 股价盘前上涨2.1%至6.81美元 ** MNKD和合作伙伴Cipla 称,印度中央药品标准控制组织(CDSCO) 已批准 (link) MNKD的胰岛素吸入粉Afrezza** 这两家公司表示,印度是全球糖尿病发病率第二高的国家** MNKD预计在2025年底前向CIPL交付产品** 根据协议,CIPL负责获得在印度分销Afrezza的监管批准以及市场营销和销售活动,而MNKD负责供应Afrezza。** 截至上次收盘,MNKD 年累计上涨 83.2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNKD","BK4139","BK4584"],"gpt_icon":0},{"id":"2486015020","title":"曼恩凯德生物医疗盘中异动 快速下跌5.01%报6.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486015020","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486015020?lang=zh_cn&edition=full","pubTime":"2024-11-26 22:43","pubTimestamp":1732632215,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日22时43分,曼恩凯德生物医疗股票出现异动,股价大幅下挫5.01%。截至发稿,该股报6.38美元/股,成交量64.4772万股,换手率0.23%,振幅3.63%。机构评级方面,在所有5家参与评级的机构中,80%的券商给予买入建议,20%的券商给予持有建议,无券商给予卖出建议。曼恩凯德生物医疗股票所在的生物技术行业中,整体跌幅为0.50%。曼恩凯德生物医疗公司简介:MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126224336abe0c251&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126224336abe0c251&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNKD","BK4139","BK4584"],"gpt_icon":0},{"id":"2484104905","title":"曼恩凯德生物医疗2024财年第三财季实现净利润11.55百万美元,同比增加571.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484104905","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484104905?lang=zh_cn&edition=full","pubTime":"2024-11-17 00:03","pubTimestamp":1731773000,"startTime":"0","endTime":"0","summary":"11月17日,曼恩凯德生物医疗公布财报,公告显示公司2024财年第三财季净利润为11.55百万美元,同比增加571.51%;其中营业收入为70.08百万美元,同比增加36.74%,每股基本收益为0.04美元。从资产负债表来看,曼恩凯德生物医疗总负债6.74亿美元,其中短期债务13.07百万美元,资产负债比为0.69,流动比率为0.05。机构评级:截至2024年11月17日,当前有5家机构对曼恩凯德生物医疗目标价做出预测,其中目标均价为9.40美元,其中最低目标价为7.00美元,最高目标价为12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000435a23e0722&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000435a23e0722&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNKD"],"gpt_icon":0},{"id":"2483384721","title":"曼恩凯德生物医疗盘中异动 临近午盘快速上涨5.32%报7.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483384721","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483384721?lang=zh_cn&edition=full","pubTime":"2024-11-15 00:55","pubTimestamp":1731603324,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日00时55分,曼恩凯德生物医疗股票出现异动,股价快速拉升5.32%。截至发稿,该股报7.33美元/股,成交量136.357万股,换手率0.49%,振幅5.89%。机构评级方面,在所有5家参与评级的机构中,80%的券商给予买入建议,20%的券商给予持有建议,无券商给予卖出建议。曼恩凯德生物医疗股票所在的生物技术行业中,整体跌幅为0.64%。曼恩凯德生物医疗公司简介:MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115005525971a69c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115005525971a69c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4584","MNKD"],"gpt_icon":0},{"id":"2481101760","title":"曼恩凯德生物医疗盘中异动 早盘股价大跌9.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481101760","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481101760?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:32","pubTimestamp":1731076368,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时32分,曼恩凯德生物医疗股票出现波动,股价急速下挫9.42%。截至发稿,该股报6.69美元/股,成交量50.0499万股,换手率0.18%,振幅5.68%。机构评级方面,在所有4家参与评级的机构中,75%的券商给予买入建议,25%的券商给予持有建议,无券商给予卖出建议。曼恩凯德生物医疗股票所在的生物技术行业中,整体涨幅为0.42%。曼恩凯德生物医疗公司简介:MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822324895bdef38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822324895bdef38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MNKD","BK4584"],"gpt_icon":0},{"id":"2481361398","title":"MannKind Corp 预计每股收益3美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481361398","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481361398?lang=zh_cn&edition=full","pubTime":"2024-11-06 11:43","pubTimestamp":1730864638,"startTime":"0","endTime":"0","summary":" * MannKind公司 预计在11月7日公布截至2024年9月30日的财报时,季度收入将出现增长。* 根据LSEG的数据,3位分析师的平均预期显示,这家总部位于康涅狄格州丹伯里的公司的营收预计将从去年同期的5125万美元增长45.4%,达到7450万美元。* LSEG分析师对MannKind公司的平均预期为每股收益3美分。* 华尔街对 MannKind 公司 12 个月目标价的中位数为 7.50 美元,高于其最新收盘价 7.26 美元。11月6日 - 以往季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"MannKind Corp 预计每股收益3美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNKD"],"gpt_icon":0},{"id":"2478148734","title":"曼恩凯德生物医疗盘中异动 快速拉升5.20%报6.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478148734","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478148734?lang=zh_cn&edition=full","pubTime":"2024-10-28 22:44","pubTimestamp":1730126676,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日22时44分,曼恩凯德生物医疗股票出现异动,股价急速拉升5.20%。截至发稿,该股报6.88美元/股,成交量50.734万股,换手率0.18%,振幅4.20%。机构评级方面,在所有4家参与评级的机构中,75%的券商给予买入建议,25%的券商给予持有建议,无券商给予卖出建议。曼恩凯德生物医疗股票所在的生物技术行业中,整体涨幅为0.58%。曼恩凯德生物医疗公司简介:MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028224437ab7becba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028224437ab7becba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MNKD","BK4584"],"gpt_icon":0},{"id":"2472673611","title":"曼恩凯德生物医疗盘中异动 快速拉升5.17%报6.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472673611","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472673611?lang=zh_cn&edition=full","pubTime":"2024-10-03 22:07","pubTimestamp":1727964437,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日22时07分,曼恩凯德生物医疗股票出现波动,股价大幅上涨5.17%。截至发稿,该股报6.62美元/股,成交量69.1327万股,换手率0.25%,振幅5.41%。机构评级方面,在所有4家参与评级的机构中,75%的券商给予买入建议,25%的券商给予持有建议,无券商给予卖出建议。曼恩凯德生物医疗股票所在的生物技术行业中,整体跌幅为0.63%。曼恩凯德生物医疗公司简介:MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003220717ab6799a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003220717ab6799a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MNKD","BK4584"],"gpt_icon":0},{"id":"2460703209","title":"曼恩凯德生物医疗盘中异动 早盘急速拉升5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460703209","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460703209?lang=zh_cn&edition=full","pubTime":"2024-08-19 21:57","pubTimestamp":1724075820,"startTime":"0","endTime":"0","summary":"北京时间2024年08月19日21时57分,曼恩凯德生物医疗股票出现波动,股价快速上涨5.06%。截至发稿,该股报5.40美元/股,成交量44.2137万股,换手率0.16%,振幅4.14%。机构评级方面,在所有4家参与评级的机构中,75%的券商给予买入建议,25%的券商给予持有建议,无券商给予卖出建议。曼恩凯德生物医疗股票所在的生物技术行业中,整体涨幅为1.00%。曼恩凯德生物医疗公司简介:MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408192157019719924e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408192157019719924e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNKD","BK4584","BK4139"],"gpt_icon":0},{"id":"2460492652","title":"曼恩凯德生物医疗2024财年第二财季实现净利润-2.01百万美元,同比增加61.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460492652","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460492652?lang=zh_cn&edition=full","pubTime":"2024-08-17 00:00","pubTimestamp":1723824030,"startTime":"0","endTime":"0","summary":"8月17日,曼恩凯德生物医疗公布财报,公告显示公司2024财年第二财季净利润为-2.01百万美元,同比增加61.86%;其中营业收入为72.39百万美元,同比增加48.92%,每股基本收益为-0.01美元。从资产负债表来看,曼恩凯德生物医疗总负债6.70亿美元,其中短期债务13.10百万美元,资产负债比为0.67,流动比率为0.05。机构评级:截至2024年8月17日,当前有5家机构对曼恩凯德生物医疗目标价做出预测,其中目标均价为7.30美元,其中最低目标价为5.00美元,最高目标价为10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170004429f31afb2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170004429f31afb2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNKD"],"gpt_icon":0},{"id":"2457770338","title":"MannKind Corp 预计每股收益1美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457770338","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457770338?lang=zh_cn&edition=full","pubTime":"2024-08-05 23:55","pubTimestamp":1722873323,"startTime":"0","endTime":"0","summary":" * MannKind公司 将于8月7日公布截至2024年6月30日的财报,预计该公司的季度收入将有所增长。* 根据LSEG的数据,4位分析师的平均预期显示,这家总部位于康涅狄格州丹伯里的公司的营收预计将从去年同期的4861万美元增长33.3%,达到6481.3万美元。* LSEG 分析师对 MannKind 公司的平均预期为每股收益 1 美分。* 华尔街对 MannKind 公司 12 个月目标价的中位数为 6.50 美元,高于其上次收盘价 5.34 美元。8月5日 - 以前季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"MannKind Corp 预计每股收益1美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNKD"],"gpt_icon":0},{"id":"2457754817","title":"曼恩凯德生物医疗盘中异动 股价大跌6.37%报5.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457754817","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457754817?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:35","pubTimestamp":1722864958,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时35分,曼恩凯德生物医疗股票出现波动,股价急速跳水6.37%。截至发稿,该股报5.00美元/股,成交量18.8727万股,换手率0.07%,振幅1.50%。最近的财报数据显示,该股实现营业收入66.26百万美元,净利润10.63百万美元,每股收益0.04美元,毛利47.67百万美元,市盈率125.00倍。曼恩凯德生物医疗股票所在的生物技术行业中,整体跌幅为1.75%。曼恩凯德生物医疗公司简介:MannKind Corp是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052135589f107166&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052135589f107166&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4584","MNKD","BK4139"],"gpt_icon":0},{"id":"2450836360","title":"曼恩凯德生物医疗盘中异动 急速上涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450836360","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450836360?lang=zh_cn&edition=full","pubTime":"2024-07-09 00:49","pubTimestamp":1720457342,"startTime":"0","endTime":"0","summary":"北京时间2024年07月09日00时49分,曼恩凯德生物医疗股票出现波动,股价急速上涨5.07%。截至发稿,该股报5.39美元/股,成交量91.9796万股,换手率0.34%,振幅4.48%。机构评级方面,在所有5家参与评级的机构中,80%的券商给予买入建议,20%的券商给予持有建议,无券商给予卖出建议。曼恩凯德生物医疗股票所在的生物技术行业中,整体涨幅为0.90%。曼恩凯德生物医疗公司简介:MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709004902af911af4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709004902af911af4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MNKD","BK4584"],"gpt_icon":0},{"id":"2446529004","title":"曼恩凯德生物医疗盘中异动 快速拉升5.19%报5.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446529004","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446529004?lang=zh_cn&edition=full","pubTime":"2024-06-25 00:43","pubTimestamp":1719247401,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日00时43分,曼恩凯德生物医疗股票出现波动,股价大幅上涨5.19%。截至发稿,该股报5.38美元/股,成交量186.988万股,换手率0.69%,振幅5.17%。曼恩凯德生物医疗股票所在的生物技术行业中,整体涨幅为1.89%。曼恩凯德生物医疗公司简介:MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625004321968164b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625004321968164b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNKD","BK4584","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mannkindcorp.com","stockEarnings":[{"period":"1week","weight":0.1196},{"period":"1month","weight":0.0263},{"period":"3month","weight":0.0817},{"period":"6month","weight":0.3526},{"period":"1year","weight":0.95},{"period":"ytd","weight":0.9286}],"compareEarnings":[{"period":"1week","weight":-0.0198},{"period":"1month","weight":-0.0012},{"period":"3month","weight":0.0411},{"period":"6month","weight":0.0903},{"period":"1year","weight":0.2557},{"period":"ytd","weight":0.2514}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Mannkind Corporation于1991年2月14日在美国特拉华州注册成立。Mannkind Corporation是一家生物制药公司,侧重于诸如糖尿病和癌症之类疗法和药品的开发、研制和推广。该公司的主导候选产品——AFREZZA吸入粉末,是一种超速效胰岛素,处于后期临床研究阶段,用于成人1型或2型糖尿病高血糖的控制治疗。AFREZZA是由该公司的专有技术圈颗粒加载到胰岛素分子里。这些加载的粒子雾化吸入后,会深入到使用AFREZZA吸入器的肺部。糖尿病是一个重大的健康问题。","yearOnYearQuotes":[{"month":1,"riseRate":0.7,"avgChangeRate":0.045334},{"month":2,"riseRate":0.4,"avgChangeRate":-0.004536},{"month":3,"riseRate":0.45,"avgChangeRate":-0.008047},{"month":4,"riseRate":0.4,"avgChangeRate":-0.028112},{"month":5,"riseRate":0.55,"avgChangeRate":0.120551},{"month":6,"riseRate":0.55,"avgChangeRate":0.062891},{"month":7,"riseRate":0.3,"avgChangeRate":-0.060302},{"month":8,"riseRate":0.428571,"avgChangeRate":0.006818},{"month":9,"riseRate":0.666667,"avgChangeRate":0.074573},{"month":10,"riseRate":0.47619,"avgChangeRate":-0.038748},{"month":11,"riseRate":0.428571,"avgChangeRate":0.022771},{"month":12,"riseRate":0.571429,"avgChangeRate":-0.012972}],"exchange":"NASDAQ","name":"曼恩凯德生物医疗","nameEN":"MannKind"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"曼恩凯德生物医疗(MNKD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供曼恩凯德生物医疗(MNKD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"曼恩凯德生物医疗,MNKD,曼恩凯德生物医疗股票,曼恩凯德生物医疗股票老虎,曼恩凯德生物医疗股票老虎国际,曼恩凯德生物医疗行情,曼恩凯德生物医疗股票行情,曼恩凯德生物医疗股价,曼恩凯德生物医疗股市,曼恩凯德生物医疗股票价格,曼恩凯德生物医疗股票交易,曼恩凯德生物医疗股票购买,曼恩凯德生物医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"曼恩凯德生物医疗(MNKD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供曼恩凯德生物医疗(MNKD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}